| Drug Name: | Naftin |
| Manufacturer: | Merz Pharmaceuticals |
| Other Info: | Pharmacokinetics:In vitro and in vivo bioavailability studies have demonstrated that naftifine penetrates the stratum corneum in sufficient concentration to inhibit the growth of dermatophytes.Following a single topical application of 1% naftifine cream to the skin of healthy subjects, systemic absorption of naftifine was approximately 6% of the applied dose. Naftifine and/or its metabolites are excreted via the urine and feces with a half-life of approximately two to three days. |
| Clinical Trials: | |